Methyldopa use should be restricted

dc.contributor.authorde Silva, H.A.en_US
dc.contributor.authorHewavisenthi, J.en_US
dc.contributor.authorWijesiriwardena, B.en_US
dc.contributor.authorFonseka, M.M.D.en_US
dc.creator.corporateauthorSri Lanka Medical Associationen_US
dc.date.accessioned2014-10-29T09:18:22Z
dc.date.available2014-10-29T09:18:22Z
dc.date.issued1999en_US
dc.description.abstractNo Abstract Available
dc.identifier.citationThe Ceylon Medical Journal. 1999; 44(4): pp.188-189en_US
dc.identifier.departmentPharmacologyen_US
dc.identifier.departmentPathologyen_US
dc.identifier.issn0009-0875 (Print)en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/1403
dc.publisherSri Lanka Medical Associationen_US
dc.subjectMethyldopaen_US
dc.subjectHypertension-drug therapy
dc.subjectMethyldopa-adverse effects
dc.subjectMethyldopa-contraindications
dc.subjectAntihypertensive Agents
dc.subjectAntihypertensive Agents-adverse effects
dc.titleMethyldopa use should be restricteden_US
dc.typeLetteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: